Dr. Weiner’s blog will return next week.
|
|
Lombardi Gala Celebrates Hope
Friends and supporters gathered for the 35th annual Lombardi Gala to celebrate life and hope in the face of cancer and rally support for funding cancer research at Georgetown Lombardi. The April 29 gala, held at The Anthem at the Wharf, raised more than $1.2 million. Read more about this year’s gala.
|
|
Center for Discovery and Innovation Hosts Colleagues at Multiple Myeloma and Lymphoma Research Symposium
The Institute for Multiple Myeloma and Lymphoma at the Hackensack Meridian Center for Discovery and Innovation (CDI) hosted world-class experts in blood cancers for the first-ever Multiple Myeloma and Lymphoma Research Symposium on April 26. Read more about this event.
|
|
TODAY: The 2023 MedStar Health-Georgetown University Research & Education Symposium — Walk-ins Welcome
|
|
The MedStar Health-Georgetown University Research & Education Symposium will be held in person today, Monday, May 8. Join investigators, educators, executive leaders, associates and collaborative partners from across our academic health center at the Bethesda North Marriott Hotel & Conference Center to share research, hear keynote speaker Eliseo J. Pérez-Stable, MD, director of the National Institute on Minority Health and Health Disparities at NIH, at 5:30 p.m., and more. Register on-site. View full symposium information.
|
|
FINAL DAY: Nominate a Candidate for the 2024 Pew-Stewart Scholars Program for Cancer Research Award
|
|
SAVE THE DATE: American Cancer Society Extramural Discovery Science Grants Workshop
Save the date for the American Cancer Society’s second webinar presentation of 2023. The American Cancer Society (ACS) Extramural Discovery Science Grants Workshop will take place on Wednesday, August 9, from 2:00 - 3:30 p.m. ACS Extramural Grants Program staffers Doug Hurst, PhD, and Nicole Lopanik, PhD, will present an orientation to the ACS’s funding mechanisms available for the October application cycles, highlighting program features such as eligibility requirements, plus new funding opportunities and updates to the application process. More information, including the registration link (all attendees must register in advance), will be sent in late June.
|
|
Copyright Support for the GUMC Community
Dahlgren Memorial Library provides copyright support to the GUMC community through different opportunities:
|
|
NCI Offers Drug Development Workshop: “Specialized Topics in Preclinical Development of Small Molecule Cancer Drugs”
The Division of Cancer Treatment and Diagnosis at NCI is hosting a virtual workshop consisting of six webinar sessions examining specialized topics that are important for the preclinical development of small molecule cancer drugs. Learn how to mitigate the risk of selected candidates during their later stages of product development and increase their chances of entering clinical evaluation. Topics will be addressed by subject matter experts from government, academia and industry. The workshop is free and consists of 60- to 90-minute webinar sessions that start at 1:00 p.m. on Thursdays and Fridays from June 22 to July 28. View more information and register.
|
|
Shared Resource Spotlight |
|
This weekly series showcases Georgetown University’s Shared Resources, which provide Georgetown Lombardi researchers with access to state-of-the-art equipment and technical expertise to support their work. |
|
Shared Resource Spotlight: Medicinal Chemistry Shared Resource
Synthetic chemistry is essential to literally every drug discovery and development program. The Medicinal Chemistry Shared Resource (MCSR) has in-depth experience across synthetic, medicinal and bioorganic chemistry, including all aspects of stereochemistry, drug design and systematic lead-compound optimization, structural analysis, and SAR mapping. The MCSR routinely conducts multistep syntheses of milligram to gram quantities of pharmaceutically relevant compounds of high quality (based on 1D and 2D 1H, 13C, 19F, 31P NMR spectroscopy, chiral chromatography, EA, HRMS, LC-MS & GC-MS, X-ray analysis, etc.). In addition, we perform SAR studies to guide drug optimization efforts; conduct structure elucidation and purity control of compounds obtained from outside sources; determine and optimize solubility and other physicochemical properties of lead compounds; perform compound mixture analysis with biological samples; and design and prepare probes or labeled drugs to evaluate drug target selectivity, metabolism, drug resistance mechanism and other characteristics.
|
|
Faculty and Staff Headshots
|
|
Thursday, May 11
4:00 - 5:00 p.m.
Presented by Tomoko Steen, PhD, professor of microbiology, Georgetown University, (pictured left) and Colm O’Huigin, PhD, head of the Microbiome and Genetics Core, Center for Cancer Research, National Cancer Institute. Join this talk in the New Research Building Auditorium or via Zoom.
|
|
Friday, May 12
10:00 - 11:00 a.m.
Meet the Speaker Session: 11:00 - 11:30 a.m.
Presented by June Chan, DSc, professor and vice chair for education, Department of Epidemiology & Biostatistics and Steven & Christine Burd-Safeway Distinguished Professor, Department of Urology, University of California, San Francisco. Join this seminar via Zoom.
|
|
Friday, May 12
1:00 - 3:00 p.m.
This virtual symposium features two conversations moderated by Pellegrino Center director Myles N. Sheehan, SJ, MD. The first is “Medical Mistrust,” among Lee Jones, MD, dean for medical education at Georgetown University School of Medicine; Christopher King, PhD, dean of the School of Health; Roberta Waite, EdD, dean of the School of Nursing; and Alyssa Newman, PhD, senior research scholar with the Kennedy Institute of Ethics. The second is “The Threat to Not-for-Profit Hospitals,” featuring hospital administrators including Michael Bezney, chief legal officer of Bon Secours Mercy Health. Sponsored by the Pellegrino Center for Clinical Bioethics. Register for this symposium.
|
|
Funding and Award Opportunities |
|
FINAL WEEK TO SUBMIT LOI:
2023 V Foundation Call for Pediatric Cancer Research Grants
This call for applications is specifically for pediatric cancer research. The sole nominee for Georgetown Lombardi may apply in either the V Scholar or the Pediatric Translational program type. Review the RFA and nomination form for each program to decide which program best fits: Pediatric V Scholar RFA / Nomination; Pediatric Translational RFA / Nomination. Nominations are due May 17; applications are due May 27. Those interested should submit a letter of intent to Sharon Levy (sgl5@georgetown.edu) by Friday, May 12.
|
|
Federal Grants Digest: Colleges & Universities Edition
A weekly curated digest of federal funding opportunities of interest to colleges and universities to support programming, research, infrastructure and other efforts, provided by Thorn Run Partners. View report (week of May 3, 2023).
|
|
Federal Lung Cancer Funding Opportunities
The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The LCRP looks to support highly innovative, high-risk early ideas as well as more advanced translation research and early stage clinical trials. In addition, it supports researcher development with a career development-focused award mechanism. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Idea Development Award: Pre-application due May 10, 5:00 p.m. ET
-
Translational Research Award: Pre-application due May 10, 5:00 p.m. ET
-
Patient-Centered Outcomes and Survivorship Award: Pre-application due July 20, 5:00 p.m. ET
|
|
Research With Activities Related to Diversity (ReWARD)
The ReWARD program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators. The grant will support scientific research in areas related to the programmatic interests of one or more of the participating NIH Institutes and Centers and ongoing DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories. View more information and application instructions. Application due date: Monday, June 5, at 5:00 p.m.
|
|
Phi Beta Psi Grant Proposal Invitation
The goal of the Phi Beta Psi Charity Trust is to advance cancer research nationwide to improve prevention, diagnosis and treatment by providing research grants to qualified investigators addressing original questions and hypotheses to be explored in basic and clinical studies in the field of cancer. Research applications must be focused on brain, breast, colorectal, endometrial, lung, ovarian, pancreatic, gastrointestinal tract or prostate cancer. Preference is given to young investigators with documented evidence of potential for conducting novel research of either basic or clinical aspects of cancer and cancer-related problems. Applications from established investigators exploring new and innovative areas of cancer research also will be considered. Post-doctoral fellows are not eligible. View full application information. Direct questions to Marcy Colley, marcycolleypbp@gmail.com. Applications for grants must be submitted to the office of the National Second Vice President by Thursday, June 15.
|
|
Federal Rare Cancers Funding Opportunities
The Rare Cancers Research Program (RCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The RCRP was initiated in 2020 to provide support for research of exceptional scientific merit in the area of rare cancers research. Rare cancers are defined as cancers affecting 6 or fewer persons per 100,000 per year in the United States. Applicants will be required to provide a justification statement explaining the relevance of the investigated cancer types/subtypes that fall under the RCRP’s definition of rare cancers. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Idea Development Award: Pre-application due June 26, 5:00 p.m. ET
-
Resource and Community Development Award: Pre-application due June 26, 5:00 p.m. ET
-
Concept Award, Pre-application due July 14, 5:00 p.m. ET
|
|
Federal Pancreatic Cancer Funding Opportunities
-
Idea Development Award: Pre-application due July 10, 5:00 p.m. ET
-
Translational Research Partnership Award: Pre-application due July 10, 5:00 p.m. ET
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | No Conference | Podium A / online
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | Protocol Writing Series – Dr. Weinberg | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | Neuro-Oncology - Dr. Komlodi-Pasztor | Podium A / Zoom
|
|
9:00 AM | Cancer Research Data Meeting | Emily Stall | “Loss of Bloom Helicase Decreases Proteasomal Turnover Causing the Accumulation of Oncogenic Proteins” | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | No Conference | Podium A / online
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series | No Lecture | Zoom
12:00 PM | No Lecture
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
